Quest Diagnostics
540 hedge funds and large institutions have $8.13B invested in Quest Diagnostics in 2015 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 190 increasing their positions, 188 reducing their positions, and 59 closing their positions.
134% more call options, than puts
Call options by funds: $50.3M | Put options by funds: $21.5M
1% more repeat investments, than reductions
Existing positions increased: 190 | Existing positions reduced: 188
0% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 59
0% less funds holding
Funds holding: 542 → 540 (-2)
1.37% less ownership
Funds ownership: 93.62% → 92.24% (-1.4%)
16% less capital invested
Capital invested by funds: $9.73B → $8.13B (-$1.6B)
55% less funds holding in top 10
Funds holding in top 10: 11 → 5 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$92.8M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$68.8M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
+$68.5M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$46.1M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$24.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSA
Davis Selected Advisers
Tucson,
Arizona
|
-$54.3M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$43.4M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
-$39.7M |
| 4 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$36.3M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$35.9M |
DGX Hedge Fund Activity: Q3 2015 in Review
540 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q3 2015, worth a combined $8.13B — down 16% from $9.73B a quarter earlier.
Fund positioning in DGX was balanced in Q3 2015: 59 funds opened new positions, 59 closed out, 190 added to existing stakes and 188 trimmed.
The largest buyer was Bank of America, adding an estimated $92.8M. The largest seller was Davis Selected Advisers, cutting an estimated $54.3M.
- 540 institutional investors held Quest Diagnostics (DGX) as of Q3 2015, down from 542 in Q2 2015.
- Funds reported $8.13B of Quest Diagnostics stock for Q3 2015, down 16% quarter-over-quarter.
- 59 funds opened new Quest Diagnostics positions in Q3 2015 and 59 closed out, a net change of 0 holders.
- The largest Quest Diagnostics buyer in Q3 2015 was Bank of America, an estimated $92.8M added.
- The largest Quest Diagnostics seller in Q3 2015 was Davis Selected Advisers, an estimated $54.3M sold.
Based on aggregated 13F filings for Q3 2015.